calendar
29,113 catalysts · 9,642 approval · 5,000 device 510k · 4,728 grant · 2,952 8k filing · 2,000 device pma · 2,000 device recall
29,113 catalysts · 9,642 approval · 5,000 device 510k · 4,728 grant · 2,952 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: ASTELLAS. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: TWI PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: VERTICAL PHARMS. Form: GEL. Route: TRANSDERMAL
Sponsor: VERTICAL PHARMS. Form: GEL. Route: TRANSDERMAL
Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INJECTION
Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: NIAGARA PHARMS. Form: SOLUTION. Route: OPHTHALMIC
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: INGENUS PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: GEL. Route: TOPICAL
Sponsor: PFIZER. Form: SWAB. Route: TOPICAL
Sponsor: PFIZER. Form: LOTION. Route: TOPICAL
Sponsor: IMPAX. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: ASTELLAS. Form: INJECTABLE. Route: INJECTION
Sponsor: WATSON LABS TEVA. Form: CAPSULE. Route: ORAL
Sponsor: CHIESI. Form: CAPSULE. Route: ORAL
Sponsor: DAIICHI SANKYO. Form: INJECTABLE. Route: INJECTION
Sponsor: INTRA-CELLULAR. Form: CAPSULE. Route: ORAL
Sponsor: INTRA-CELLULAR. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: SUBCUTANEOUS